James Kelly | EVP and CFO |
Mihael Polymeropoulos | President and CEO |
Chris Howerton | Jefferies |
Joel Beatty | Citi |
Jason Butler | JMP Securities |
Pete Stavropoulos | Cantor Fitzgerald |
Esther Rajavelu | Oppenheimer |
Derek Archila | Stifel |
Good day ladies and gentlemen and welcome to the Vanda Pharmaceutical’s fourth quarter 2018 earnings conference call. At this time, all participants are in a listen-only mode. [Operator Instructions] Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder today’s conference is being recorded. I’d now like to introduce your host for today’s conference Mr.